Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

In Bedford, Massachusetts, on June 22, 2026, Ocular Therapeutix, Inc. provided details that they have awarded inducement awards to Ms. Kelley Allison, the newly appointed SVP of Market Access and Health Policy. Ocular, a biopharmaceutical company listed on NASDAQ under the ticker symbol OCUL, focuses on enhancing the retina experience. The awards were granted under Ocular's 2019 Inducement Stock Incentive Plan to secure Ms. Allison's employment, aligning with Nasdaq Listing Rule 5635(c)(4).